Point-of-care assays for tuberculosis: Role of nanotechnology/microfluidics

Biotechnology Advances

Volumn 31, Issue 4, 2013, Pages 438-449

  Wang, ShuQi ^a   Inci, Fatih ^a   De Libero, Gennaro ^b,c   Singhal, Amit ^b   Demirci, Utkan ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Microfluidics; Nanotechnology; Point of care; Tuberculosis

Indexed keywords

CURRENT TECHNOLOGY; DELAYED DIAGNOSIS; DIAGNOSTIC TESTS; INFECTIOUS DISEASE; NEW APPROACHES; POINT OF CARE; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

MICROFLUIDICS; NANOTECHNOLOGY;

TUBES (COMPONENTS);

ADVANCED TECHNOLOGY; DISEASE CONTROL; DISEASE TREATMENT; EPIDEMIC; HEAVY METAL; INFECTIOUS DISEASE; NANOTECHNOLOGY; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ANIMAL; DIAGNOSTIC PROCEDURE; GENETIC PROCEDURES; HOSPITAL INFORMATION SYSTEM; HUMAN; METHODOLOGY; MICROFLUIDICS; NANOTECHNOLOGY; REVIEW; TUBERCULOSIS;

ANIMALS; BIOSENSING TECHNIQUES; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; MICROFLUIDICS; NANOTECHNOLOGY; POINT-OF-CARE SYSTEMS; TUBERCULOSIS;

EID: 84875000190     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2013.01.006     Document Type: Review

References (79)

1. Alyassin M.A., Moon S., Keles H.O., Manzur F., Lin R.L., Haeggstrom E., et al. Rapid automated cell quantification on HIV microfluidic devices. Lab Chip 2009, 9:3364-3369.
2. Andersen P., Munk M.E., Pollock J.M., Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356:1099-1104.
3. Aryan E., Makvandi M., Farajzadeh A., Huygen K., Bifani P., Mousavi S.L., et al. A novel and more sensitive loop-mediated isothermal amplification assay targeting IS6110 for detection of Mycobacterium tuberculosis complex. Microbiol Res 2010, 165:211-220.
4. Barry C.E., Boshoff H.I., Dartois V., Dick T., Ehrt S., Flynn J., et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009, 7:845-855.
5. Behr M.A., Warren S.A., Salamon H., Hopewell P.C. Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999, 353:444-449.
6. Boehme C.C., Nabeta P., Henostroza G., Raqib R., Rahim Z., Gerhardt M., et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007, 45:1936-1940.
7. Boehme C.C., Nabeta P., Hillemann D., Nicol M.P., Shenai S., Krapp F., et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015.
8. Boehme C.C., Nicol M.P., Nabeta P., Michael J.S., Gotuzzo E., Tahirli R., et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505.
9. Breslauer D.N., Maamari R.N., Switz N.A., Lam W.A., Fletcher D.A. Mobile phone based clinical microscopy for global health applications. PLoS One 2009, 4.
10. Buijtels P.C., Willemse-Erix H.F., Petit P.L., Endtz H.P., Puppels G.J., Verbrugh H.A., et al. Rapid identification of mycobacteria by Raman spectroscopy. J Clin Microbiol 2008, 46:961-965.
11. Cattamanchi A., Smith R., Steingart K.R., Metcalfe J.Z., Date A., Coleman C., et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011, 56:230-238.
12. Chen J., Zhang R., Wang J., Liu L., Zheng Y., Shen Y., et al. Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS One 2011, 6:e26827.
13. Chin C.D., Laksanasopin T., Cheung Y.K., Steinmiller D., Linder V., Parsa H., et al. Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med 2011, 17:1015-1019.
14. Christodoulides N., Mohanty S., Miller C.S., Langub M.C., Floriano P.N., Dharshan P., et al. Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip 2005, 5:261-269.
15. Chun A.L. Nanoparticles offer hope for TB detection. Nat Nanotechnol 2009, 4:698-699.
16. Cobelens F.G., Egwaga S.M., van Ginkel T., Muwinge H., Matee M.I., Borgdorff M.W. Tuberculin skin testing in patients with HIV infection: Limited benefit of reduced cutoff values. Clin Infect Dis 2006, 43:634-639.
17. Costa P., Amaro A., Botelho A., Inacio J., Baptista P.V. Gold nanoprobe assay for the identification of mycobacteria of the Mycobacterium tuberculosis complex. Clin Microbiol Infect 2010, 16:1464-1469.
18. Davies P.D., Pai M. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis 2008, 12:1226-1234.
19. Denkinger C.M., Pai M. Point-of-care tuberculosis diagnosis: are we there yet?. Lancet Infect Dis 2012, 12:169-170.
20. Dheda K., van Zyl Smit R., Badri M., Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009, 15:188-200.
21. Diaz-Gonzalez M., Gonzalez-Garcia M.B., Costa-Garcia A. Immunosensor for Mycobacterium tuberculosis on screen-printed carbon electrodes. Biosens Bioelectron 2005, 20:2035-2043.
22. Dimov I.K., Basabe-Desmonts L., Garcia-Cordero J.L., Ross B.M., Park Y., Ricco A.J., et al. Stand-alone self-powered integrated microfluidic blood analysis system (SIMBAS). Lab Chip 2011, 11:845-850.
23. Dowdy D.W., Steingart K.R., Pai M. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 2011, 8:e1001074.
24. Farhat M., Greenaway C., Pai M., Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuberc Lung Dis 2006, 10:1192-1204.
25. Geojith G., Dhanasekaran S., Chandran S.P., Kenneth J. Efficacy of loop mediated isothermal amplification (LAMP) assay for the laboratory identification of Mycobacterium tuberculosis isolates in a resource limited setting. J Microbiol Methods 2011, 84:71-73.
26. Goncalves I.M., Alves D.C. Carvalho A, do Ceu Brito M, Calvario F. Duarte R. Tuberculosis and Venous Thromboembolism: a case series. Cases Journal 2009, 2:9333.
27. Gurkan U.A., Moon S., Geckil H., Xu F., Wang S., Lu T.J., et al. Miniaturized lensless imaging systems for cell and microorganism visualization in point-of-care testing. Biotechnol J 2011, 6:138-149.
28. He F., Zhang R. Rapid diagnosis of M. tuberculosis using a piezoelectric immunosensor. Anal Sci 2002, 18:397-401.
29. He F., Zhao J., Zhang L., Su X. A rapid method for determining Mycobacterium tuberculosis based on a bulk acoustic wave impedance biosensor. Talanta 2003, 59:935-941.
30. Hobby G.L., Holman A.P., Iseman M.D., Jones J.M. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother 1973, 4:94-104.
31. Homola J. Surface plasmon resonance sensors for detection of chemical and biological species. Chem Rev 2008, 108:462-493.
32. Hong S.C., Chen H.X., Lee J., Park H.K., Kim Y.S., Shin H.C., et al. Ultrasensitive immunosensing of tuberculosis CFP-10 based on SPR spectroscopy. Sens Actuator B-Chem 2011, 156:271-275.
33. Höök F., Kasemo B., Nylander T., Fant C., Sott K., Elwing H. Variations in coupled water, viscoelastic properties, and film thickness of a Mefp-1 protein film during adsorption and cross-linking: a quartz crystal microbalance with dissipation monitoring, ellipsometry, and surface plasmon resonance study. Anal Chem 2001, 73:5796-5804.
34. Iwamoto T., Sonobe T., Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J Clin Microbiol 2003, 41:2616-2622.
35. Kim Y.G., Moon S., Kuritzkes D.R., Demirci U. Quantum dot-based HIV capture and imaging in a microfluidic channel. Biosens Bioelectron 2009, 25:253-258.
36. Lawn S.D., Kerkhoff A.D., Vogt M., Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012, 12:201-209.
37. Lee H., Sun E., Ham D., Weissleder R. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med 2008, 14:869-874.
38. Ling D.I., Pai M., Davids V., Brunet L., Lenders L., Meldau R., et al. Are interferon-gamma release assays useful for diagnosing active tuberculosis in a high-burden setting?. Eur Respir J 2011, 38:649-656.
39. Mazurek G.H., Jereb J., Lobue P., Iademarco M.F., Metchock B., Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005, 54:49-55.
40. McNerney R., Daley P. Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat Rev Microbiol 2011, 9:204-213.
41. McNerney R., Wondafrash B.A., Amena K., Tesfaye A., McCash E.M., Murray N.J. Field test of a novel detection device for Mycobacterium tuberculosis antigen in cough. BMC Infect Dis 2010, 10:161.
42. Metcalfe J.Z., Everett C.K., Steingart K.R., Cattamanchi A., Huang L., Hopewell P.C., et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 2011, 204(Suppl. 4):S1120-S1129.
43. Moon S., Keles H.O., Ozcan A., Khademhosseini A., Haeggstrom E., Kuritzkes D., et al. Integrating microfluidics and lensless imaging for point-of-care testing. Biosens Bioelectron 2009, 24:3208-3214.
44. Moon S., Gurkan U.A., Blander J., Fawzi W.W., Aboud S., Mugusi F., et al. Enumeration of CD4+ T-cells using a portable microchip count platform in Tanzanian HIV-infected patients. PLoS One 2011, 6:e21409.
45. Nagel T., Ehrentreich-Forster E., Singh M., Schmitt K., Brandenburg A., Berka A., et al. Direct detection of tuberculosis infection in blood serum using three optical label-free approaches. Sens Actuator B-Chem 2008, 129:934-940.
46. Niemz A., Ferguson T.M., Boyle D.S. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol 2011, 29:240-250.
47. Notomi T., Okayama H., Masubuchi H., Yonekawa T., Watanabe K., Amino N., et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000, 28.
48. Padilla E., Gonzalez V., Manterola J.M., Perez A., Quesada M.D., Gordillo S., et al. Comparative evaluation of the new version of the INNO-LiPA Mycobacteria and genotype Mycobacterium assays for identification of Mycobacterium species from MB/BacT liquid cultures artificially inoculated with Mycobacterial strains. J Clin Microbiol 2004, 42:3083-3088.
49. Pai N.P., Pai M. Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Discov Med 2012, 13:35-45.
50. Pandey B.D., Poudel A., Yoda T., Tamaru A., Oda N., Fukushima Y., et al. Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients. J Med Microbiol 2008, 57:439-443.
51. Parsons L.M., Somoskovi A., Gutierrez C., Lee E., Paramasivan C.N., Abimiku A., et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev 2011, 24:314-350.
52. Peh W.Y.X., Reimhult E., Teh H.F., Thomsen J.S., Su X. Understanding ligand binding effects on the conformation of estrogen receptor α-DNA complexes: a combinational quartz crystal microbalance with dissipation and surface plasmon resonance study. Biophys J 2007, 92:4415-4423.
53. Peter J.G., Theron G., van Zyl-Smit R., Haripersad A., Mottay L., Kraus S., et al. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 2012, 40:1211-1220.
54. Piatek A.S., Tyagi S., Pol A.C., Telenti A., Miller L.P., Kramer F.R., et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 1998, 16:359-363.
55. Pinto L.M., Grenier J., Schumacher S.G., Denkinger C.M., Steingart K.R., Pai M. Immunodiagnosis of tuberculosis: state of the art. Med Princ Pract 2012, 21:4-13.
56. Prabhakar N., Arora K., Arya S.K., Solanki P.R., Iwamoto M., Singh H., et al. Nucleic acid sensor for M. tuberculosis detection based on surface plasmon resonance. Analyst 2008, 133:1587-1592.
57. Ren J., He F., Yi S., Cui X. A new MSPQC for rapid growth and detection of Mycobacterium tuberculosis. Biosens Bioelectron 2008, 24:403-409.
58. Sarkola A., Makinen J., Marjamaki M., Marttila H.J., Viljanen M.K., Soini H. Prospective evaluation of the GenoType assay for routine identification of mycobacteria. Eur J Clin Microbiol Infect Dis 2004, 23:642-645.
59. Shafiee H, Jahangir M, Inci F, Wang S, Willenbrecht RBM, Giguel FF, et al. Acute HIV-1 Detection through Label-Free Electrical Sensing of Viral Nano-Lysate on-Chip. Small in press, http://dx.doi.org/10.1002/smll.201202195.
60. Siddiqi K., Lambert M.L., Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 2003, 3:288-296.
61. Soo P.C., Horng Y.T., Chang K.C., Wang J.Y., Hsueh P.R., Chuang C.Y., et al. A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens. Mol Cell Probes 2009, 23:240-246.
62. Steingart K.R., Flores L.L., Dendukuri N., Schiller I., Laal S., Ramsay A., et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med 2011, 8.
63. Steingart K.R., Flores L.L., Dendukuri N., Schiller I., Laal S., Ramsay A., et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med 2011, 8:e1001062.
64. Stop TB Partnership WHO The Global Plan to Stop TB 2011-2015: transforming the fight towards elimination of tuberculosis [accessed on October 23rd, 2012]. http://www.stoptb.org/global/plan/.
65. Thanyani S.T., Roberts V., Siko D.G.R., Vrey P., Verschoor J.A. A novel application of affinity biosensor technology to detect antibodies to mycolic acid in tuberculosis patients. J Immunol Methods 2008, 332:61-72.
66. Thiruppathiraja C., Kamatchiammal S., Adaikkappan P., Santhosh D.J., Alagar M. Specific detection of Mycobacterium sp genomic DNA using dual labeled gold nanoparticle based electrochemical biosensor. Anal Biochem 2011, 417:73-79.
67. Tomita N., Mori Y., Kanda H., Notomi T. Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products. Nat Protoc 2008, 3:877-882.
68. Tostmann A., Kik S.V., Kalisvaart N.A., Sebek M.M., Verver S., Boeree M.J., et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 2008, 47:1135-1142.
69. Van Rie A., Page-Shipp L., Scott L., Sanne I., Stevens W. Xpert((R)) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?. Expert Rev Mol Diagn 2010, 10:937-946.
70. Wang S., Xu F., Demirci U. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol Adv 2010, 28:770-781.
71. Wang S., Zhao X., Khimji I., Akbas R., Qiu W., Edwards D., et al. Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care. Lab Chip. 2011, 11:341-348.
72. Wang S., Esfahani M., Gurkan U.A., Inci F., Kuritzkes D., Demirci U. Efficient on-chip isolation of HIV subtypes. Lab Chip 2012, 12:1508-1515.
73. Wang S., Inci F., Chaunzwa T., Ramanujam A., Vasudevan A., Subramanian S., et al. Portable microfluidic chip for detection of Escherichia coli in produce and blood. Int J Nanomedicine 2012, 7:2591-2600.
74. WHO Commercial serodiagnostic tests for diagnosis of tuberculosis [Accessed on January 26th, 2012]. http://whqlibdoc.who.int/publications/2011/9789241502054_eng.pdf.
75. WHO Global tuberculosis control 2011 [accessed on January 26th, 2012]. http://www.who.int/tb/publications/global_report/en/.
76. WHO/Global Fund Partners call for increased commitment to tackle MDR-TB. 2011c [Accessed on January 26, 2012]. http://www.who.int/mediacentre/news/releases/2011/TBday_20110322/en/index.html.
77. Xie H., Mire J., Kong Y., Chang M., Hassounah H.A., Thornton C.N., et al. Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Nat Chem 2012, 4:802-809.
78. Yeo W.H., Liu S., Chung J.H., Liu Y.L., Lee K.H. Rapid detection of Mycobacterium tuberculosis cells by using microtip-based immunoassay. Anal Bioanal Chem 2009, 393:1593-1600.
79. Zwerling A., Behr M.A., Verma A., Brewer T.F., Menzies D., Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med 2011, 8:e1001012.